WO2002034240A3 - Delayed and sustained release formulations and method of use thereof - Google Patents
Delayed and sustained release formulations and method of use thereof Download PDFInfo
- Publication number
- WO2002034240A3 WO2002034240A3 PCT/US2001/032446 US0132446W WO0234240A3 WO 2002034240 A3 WO2002034240 A3 WO 2002034240A3 US 0132446 W US0132446 W US 0132446W WO 0234240 A3 WO0234240 A3 WO 0234240A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- sustained release
- release formulations
- delayed
- drug
- delivery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01988581A EP1330239A2 (en) | 2000-10-26 | 2001-10-18 | Delayed and sustained release formulations and method of use thereof |
AU2002221273A AU2002221273A1 (en) | 2000-10-26 | 2001-10-18 | Delayed and sustained release formulations and method of use thereof |
JP2002537294A JP2004512298A (en) | 2000-10-26 | 2001-10-18 | Delayed and sustained release formulations and methods of using them |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69590300A | 2000-10-26 | 2000-10-26 | |
US09/695,903 | 2000-10-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002034240A2 WO2002034240A2 (en) | 2002-05-02 |
WO2002034240A3 true WO2002034240A3 (en) | 2002-10-10 |
Family
ID=24794914
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/032446 WO2002034240A2 (en) | 2000-10-26 | 2001-10-18 | Delayed and sustained release formulations and method of use thereof |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1330239A2 (en) |
JP (1) | JP2004512298A (en) |
AU (1) | AU2002221273A1 (en) |
WO (1) | WO2002034240A2 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0203296D0 (en) | 2002-02-12 | 2002-03-27 | Glaxo Group Ltd | Novel composition |
US8637512B2 (en) | 2002-07-29 | 2014-01-28 | Glaxo Group Limited | Formulations and method of treatment |
NZ546148A (en) | 2003-09-26 | 2009-05-31 | Alza Corp | Drug coating providing high drug loading and methods for providing the same |
DE102004014828A1 (en) * | 2004-03-24 | 2005-11-03 | Hexal Ag | Pharmaceutical formulation, for oral administration, has a coating of film-forming polymers free of surfactants and anti-foaming agents |
US8377906B2 (en) | 2004-06-04 | 2013-02-19 | Ethicon, Inc. | Compositions and methods for preventing or reducing postoperative ileus and gastric stasis |
US8129359B2 (en) * | 2004-06-04 | 2012-03-06 | Ethicon, Inc. | Composition and method for treating post-surgical pain |
US8541026B2 (en) | 2004-09-24 | 2013-09-24 | Abbvie Inc. | Sustained release formulations of opioid and nonopioid analgesics |
FR2881049B1 (en) * | 2005-01-24 | 2008-12-26 | Vetoquinol Sa Sa | MEDICAMENT FOR ORAL ADMINISTRATION COMPRISING A CYCLO-OXYGENASE-2 INHIBITOR, AND PROCESS FOR PREPARING THE SAME |
AU2010211985A1 (en) * | 2009-01-22 | 2011-08-11 | Abbott Healthcare Private Limited | Chronotherapeutic pharmaceutical composition |
US8945622B2 (en) | 2009-03-09 | 2015-02-03 | Council Of Scientific And Industrial Research | Sustained release composition of therapeutic agent |
WO2012059937A1 (en) * | 2010-11-01 | 2012-05-10 | Abbott Healthcare Private Limited | Modifies release pharmaceutical compositons for nsaids |
CN105816436B (en) * | 2016-03-22 | 2019-10-22 | 广州共禾医药科技有限公司 | A kind of Pantoprazole enteric-coated micro-pill, Pantoprazole enteric slow-release tablet agent and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0605174A1 (en) * | 1992-12-23 | 1994-07-06 | Kinaform Technology Inc. | Delayed, Sustained-release pharmaceutical preparation |
US5711967A (en) * | 1991-06-17 | 1998-01-27 | Spirig Ag, Pharmazeutische Praeparate | Oral diclofenac preparation |
-
2001
- 2001-10-18 EP EP01988581A patent/EP1330239A2/en not_active Withdrawn
- 2001-10-18 AU AU2002221273A patent/AU2002221273A1/en not_active Abandoned
- 2001-10-18 WO PCT/US2001/032446 patent/WO2002034240A2/en not_active Application Discontinuation
- 2001-10-18 JP JP2002537294A patent/JP2004512298A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5711967A (en) * | 1991-06-17 | 1998-01-27 | Spirig Ag, Pharmazeutische Praeparate | Oral diclofenac preparation |
EP0605174A1 (en) * | 1992-12-23 | 1994-07-06 | Kinaform Technology Inc. | Delayed, Sustained-release pharmaceutical preparation |
Also Published As
Publication number | Publication date |
---|---|
EP1330239A2 (en) | 2003-07-30 |
WO2002034240A2 (en) | 2002-05-02 |
JP2004512298A (en) | 2004-04-22 |
AU2002221273A1 (en) | 2002-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000041681A3 (en) | MEDICINAL FORMULATIONS CONTAINING AN OPIOID AND AN α-ANTAGONIST | |
WO2003082247A3 (en) | Drug microparticles | |
MA26800A1 (en) | AEROSOL SYSTEMS AND METHODS FOR PHARMACEUTICAL FORMULATIONS. | |
WO2006039336A3 (en) | Conveniently implantable sustained release drug compositions | |
WO2006035417A3 (en) | Dihydropyrimidine microcapsule - formulations | |
WO2006124047A3 (en) | Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent | |
WO2003028660A3 (en) | Drug delivery devices and methods | |
EP1690530A3 (en) | Sustained release pharmaceutical composition free of food effect and a method for alleviating food effect in drug release | |
WO2000040203A3 (en) | Polymeric delivery agents and delivery agent compounds | |
AU2003280087A1 (en) | Dosage forms for increasing the solubility and extending the release of drugs such as e.g. topiramate and phenyton | |
WO2007008752A3 (en) | Sustained release pharmaceutical compositions for highly water soluble drugs | |
DK1183014T3 (en) | Flavored controlled release oral pharmaceutical compositions | |
ZA200301813B (en) | Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them. | |
AU2003258209A1 (en) | Active agent delivery systems, medical devices, and methods | |
MXPA03003235A (en) | Delayed release pharmaceutical formulations. | |
AU2002318759A1 (en) | Remedies for diseases with bone mass loss having EP4 agonists as the active ingredient | |
AU2003274681A1 (en) | Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release | |
WO2004009445A3 (en) | Packaging and dispensing of rapid dissolve dosage form | |
AU3076700A (en) | 2h-phthalazin-1-one derivatives and drugs comprising these derivatives as the active ingredient | |
WO2001060335A3 (en) | Delivery systems using preformed biodegradable polymer compositions and methods | |
EP1391200A4 (en) | Drug preparations | |
AU2001283359A1 (en) | Drug release (delivery system) | |
WO2006124681A3 (en) | Oral drug delivery system and methods of use thereof | |
WO2002019969A3 (en) | (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents | |
WO2002067895A3 (en) | Implant dosage form and use thereof for the delivery of a cholesterol lowering agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002537294 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001988581 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001988581 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001988581 Country of ref document: EP |